0000876661-24-000563.txt : 20240708
0000876661-24-000563.hdr.sgml : 20240708
20240708094415
ACCESSION NUMBER: 0000876661-24-000563
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20240708
DATE AS OF CHANGE: 20240708
EFFECTIVENESS DATE: 20240708
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: 10X Capital Venture Acquisition Corp. III
CENTRAL INDEX KEY: 0001848948
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41216
FILM NUMBER: 241103534
BUSINESS ADDRESS:
STREET 1: 1 WORLD TRADE CENTER
STREET 2: FLOOR 85
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 257-0069
MAIL ADDRESS:
STREET 1: 1 WORLD TRADE CENTER
STREET 2: FLOOR 85
CITY: NEW YORK
STATE: NY
ZIP: 10007
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE AMERICAN LLC
CENTRAL INDEX KEY: 0001143313
ORGANIZATION NAME:
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5414
MAIL ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE MKT LLC
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Amex
DATE OF NAME CHANGE: 20090402
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
25-NSE
1
primary_doc.xml
X0203
0001143313
NYSE AMERICAN LLC
0001848948
10X Capital Venture Acquisition Corp. III
001-41216
1 World Trade Center, 85th Floor
New York
NY
NEW YORK
10007
(212) 257-0069
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
17 CFR 240.12d2-2(b)
Emily Fuhrman
Analyst, Regulation
2024-07-08
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
NYSE American LLC ("NYSE American" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (the "Warrants") of 10X Capital Venture Acquisition Corp. III (the "Company") from listing and registration on the Exchange at the opening of business on July 19, 2024, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Warrants are no longer suitable for continued listing and trading on the Exchange.
The Exchange has determined that the Company's Warrants are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide (the "Company Guide") due to the low trading price of the Warrants.
On June 24, 2024, the Exchange determined that the Warrants of the Company should be suspended from trading and directed the preparation and filing with the Commission of this application for the removal of the Warrants from listing and registration on the NYSE American. The Company was notified on June 25, 2024.
Pursuant to the above authorization, a press release regarding the proposed delisting was issued and posted on the Exchange's website on June 25, 2024. Trading in the Warrants was suspended on June 24, 2024.
The Company had a right to appeal to a Committee of the Board of Directors of the Exchange the determination to delist the Warrants, provided it filed a written request for such a review with the Secretary of the Exchange within seven calendar days of receiving notice of the delisting determination. The Company did not file such request within the specified period. Consequently, all conditions precedent under SEC Rule 12d2-2(b) to the filing of this application have been satisfied.